Illness	Number of cases
Hyperplasia of prostate (N40)	252
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	171
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	160
Malignant neoplasm of prostate (C61)	115
Calculus of kidney and ureter - Calculus of kidney (N20.0)	98
Calculus of kidney and ureter - Calculus of ureter (N20.1)	97
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	83
Acute tubulo-interstitial nephritis (N10)	72
Inflammatory diseases of prostate - Prostatocystitis (N41.3)	67
Obstructive uropathy and refluxuropathy - Pyonephrosis - Hydronephrosis in obstruction by ureteral stone with infection of the kidney (N13.63)	56

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	691
Insertion, exchange or removal of a ureteral stent (8-137.00)	349
Insertion, exchange or removal of a ureteral stent (8-137.10)	287
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	278
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	229
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	216
Surgical creation of a connection between the urinary bladder and skin of the abdomen for artificial urinary drainage (5-572.1)	186
(8-137.20)	186
(9-984.7)	119
(9-984.8)	117

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Brustkrebs

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
58	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
36	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
22	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Editors of scientific journals/textbooks
Participation in multi-centre phase III/IV studies
Participation in multi-centre Phase I/II studies